Objective: To describe prevalence, time of diagnosis, and type of birth in children and fetuses with urinary tract (UT) anomalies after the introduction of the anomaly scan in the Netherlands in
| INTRODUCTION
Renal urinary tract (UT) anomalies are among the most common congenital anomalies. The average European prevalence was 32.8/ 10 000 births over the period of 2010-2014. 1 Urinary tract anomalies represent a broad phenotypic spectrum, ranging from renal agenesis, cystic kidney diseases, hydronephrosis, and lower-urinary tract obstructions, all with a wide range in severity. Some anomalies are incompatible with life, such as bilateral renal agenesis, while other anomalies are mild and may remain undetected if not diagnosed by ultrasound. Risk factors for UT anomalies include genetic and nongenetic factors, 2 such as maternal obesity 3 and fertility treatment, 4 whereas the use of folic acid is reported to reduce the risk. 5 Urinary tract anomalies are more commonly observed in male fetuses. 6 Because congenital UT anomalies are the cause of 30 to 40% of cases of end-stage renal disease, especially in young children, early diagnosis is important to start therapy and minimize renal damage. 7 Before the introduction of the prenatal screening program in the Netherlands in 2007, ultrasound scans were only performed on clinical indication (suspected poor or excessive fetal growth, including oligohydramnios or polyhydramnios, positive family history for congenital anomalies, use of teratogens, and diabetes) or for keepsake.
In 2007, a national prenatal screening program was introduced in the Netherlands, including the combined first trimester screening for trisomies 21, 13, and 18 and an anomaly scan between 18 and 22 weeks of gestation. 8 The latter is offered free of charge to all pregnant women with an uptake of more than 90%. When an anomaly is suspected, the pregnant woman is referred to a Fetal Medicine Unit, a tertiary center for prenatal diagnosis where an advanced ultrasound scan is performed by a specialist and, if appropriate, additional genetic testing is offered.
The aim of this study was to examine whether in the period after the introduction of the prenatal screening program, there were specific trends in the prevalence of UT anomalies, clinical presentation, time of diagnosis, and outcome of pregnancies in which the fetus was affected with an anomaly of the urinary tract.
| METHODS
We conducted a study within Eurocat Northern Netherlands, a popu- What's already known about this topic?
• Urinary tract (UT) anomalies are among the most frequent congenital anomalies.
What does this study add?
• After the introduction of the prenatal screening program, an increase in prevalence of anomalies of the collecting system was observed.
• Because of the high uptake of the second trimester anomaly scan and improved skills of the sonographers, more UT anomalies are detected prenatally that would otherwise remain undetected, because of no or limited clinical consequences.
between 60.0% (in 2014) and 90.0% (in 2010) (X 2 for trend P = .581; Figure 2 ). Prenatal detection of cases with an anomaly of the collecting system was 70.4% over the study period and increased from 55.9% in 2008 to 81.3% in 2014 (X 2 for trend P < .001; Figure 2 ). For specific UT anomalies of the renal parenchyma and collecting system, the prenatal detection varied between 0% for epispadias and over 90% for mulcticystic dysplastic kidney, ureteropelvic junction stenosis, stenosis of urethra or bladder neck, and absence of bladder and urethra (supporting table) . The prenatal detection rates for migration anomalies and multiple anomalies were 65% and 85%, respectively, over the total period.
There was a significant difference in prenatal detection according to the different clinical presentations of UT anomalies. The proportion of prenatally detected UT anomalies was highest among cases presenting as isolated UT anomalies (79.9%, n = 270). Of the UT anomalies that were part of a syndrome or genetic condition or of MCA, prenatal detection occurred in 62.5% (n = 50) and 47.1%
(n = 32), respectively (P < .001). The timing of prenatal detection varied according to the different UT categories. Over the total period, 17%
(n = 59) of the prenatally detected UT anomalies were detected after 22 weeks of gestation; these were mainly anomalies of the collecting system (n = 46).
The vast majority of fetuses with a UT anomaly were LBs, 81.9%
(n = 399). Terminations of pregnancy and intrauterine deaths occurred in 14.8% (n = 72) and 3.3% (n = 16), respectively. No trend in status at birth was observed over the study period. The latter, however, differed by clinical presentation and UT category ( because of better diagnostic sensitivity of ultrasound. 12 Garne et al 13 found in a European cohort study on hydronephrosis that the availability of prenatal screening services was related to the variability in prevalence. If there was no standard prenatal screening, the prevalence of congenital hydronephrosis was in general lower.
The increasing prevalence in anomalies of the collecting system in our study is most likely also the result of improved prenatal diagnosis because of the high uptake of the second trimester anomaly scan and improved skills of the sonographers. The prenatal screening program was swiftly introduced in 2007, and many sonographers were trained at that time to perform the anomaly scan. The uptake of the anomaly scan was over 90% during the study period and did not increase in a substantial way. During the anomaly scan, a complete fetal anatomy survey is carried out, including the urinary system (US). The sonographer investigates the bladder (size and filling), presence of both kidneys, echogenicity of renal parenchyma, and diameter of the pyela. As a consequence, a large majority of the UT anomalies are detected prenatally, 14 The higher prevalence rate found in this study supports the conclusion that the anomaly scan has led to more UT anomaly diagnoses.
Although the prenatal detection rate increased during the study period to over 80%, no increase in termination of pregnancies was observed in our cohort. Our results are in line with other studies that documented high prenatal detection rates and relatively low termination rates. In a European study on multicystic dysplastic kidney Midlands (England), a prenatal diagnosis rate of 51% was observed in all cases and somewhat higher in complex cases, compared to isolated cases. Termination of pregnancy was performed in 41% of complex cases and in 19% of isolated cases. 17 These proportions are comparable with our study where TOP was chosen in 41% of cases with a genetic condition or syndrome diagnosis and 33% of the MCA cases.
In general, TOP is associated with more severe types of UT anomalies.
Anomalies of the collecting system represented the largest group in our study. This group includes primary hydronephrosis, which is a common obstructive anomaly, but also one of the UT anomalies that may have a favorable prognosis. In a recent study in one Dutch hospital, 24% of the children who were prenatally diagnosed with hydronephrosis were not confirmed postnatally or had mild dila- We performed a population-based cohort study, using data from a high-quality registry for congenital anomalies. For each case, there was detailed information available on UT and possible additional anomalies, coded by trained registry staff. When performed, information from genetic tests was available. Therefore, we were able to classify the cases very precisely according to clinical presentation. Another strength is that we had detailed information on the time of detection and type of birth for each case. Since Eurocat only collects data on fetuses and infants with an anomaly, we were not able to include fetuses where an UT anomaly was suspected prenatally but had resolved during pregnancy. However, it was not the aim of our study to evaluate the prognosis and outcome of prenatally detected UT anomalies. The registry uses multiple sources for case-finding. Although the registry tries to capture all the cases with a congenital (UT) anomaly, the registration may not be complete, due to nonconsent of the parents. Approximately 7% of the parents do not give consent for registration. Also, it may take some time to capture all the cases through active case-finding. Therefore, the most recent years may be less complete.
In conclusion, after the introduction of the prenatal screening program, we observed a nonsignificantly increased prevalence of all UT anomalies and a significant increase in the prevalence of anomalies of the collecting system. Currently, over 80% of the UT anomalies are detected prenatally. Some of these anomalies might have remained undetected without anomaly scan, because of no or limited clinical consequences and may cause (unnecessary) anxiety for the future parents. Although more UT anomalies were prenatally diagnosed, no increase in termination of pregnancies was observed. It is important to improve information on follow-up of children prenatally diagnosed with UT anomalies to provide parents with correct information on the long-term prognosis.
